DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer
about
DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer
description
scientific article published on 22 August 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2018
@uk
name
DNA Replication Licensing Prot ...... peutic Target in Breast Cancer
@en
DNA Replication Licensing Prot ...... peutic Target in Breast Cancer
@nl
type
label
DNA Replication Licensing Prot ...... peutic Target in Breast Cancer
@en
DNA Replication Licensing Prot ...... peutic Target in Breast Cancer
@nl
prefLabel
DNA Replication Licensing Prot ...... peutic Target in Breast Cancer
@en
DNA Replication Licensing Prot ...... peutic Target in Breast Cancer
@nl
P2093
P2860
P50
P356
P1433
P1476
DNA Replication Licensing Prot ...... peutic Target in Breast Cancer
@en
P2093
Henrique Neves
Hiu-Fung Yuen
Muhammad Jameel
Shu-Dong Zhang
Youzhi Zhu
Yuchen Bai
P2860
P356
10.3390/CANCERS10090282
P407
P577
2018-08-22T00:00:00Z